Ascendis Pharma A/SASNDNASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$-130.89M
↑ 53% vs avg
Percentile
P54
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-277.54M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-130.89M | +53.0% |
| 2024 | $-278.76M | +38.8% |
| 2023 | $-455.54M | +18.9% |
| 2022 | $-561.81M | -24.4% |
| 2021 | $-451.79M | -36.6% |
| 2020 | $-330.62M | -45.8% |
| 2019 | $-226.72M | -46.5% |
| 2018 | $-154.76M | -38.7% |
| 2017 | $-111.54M | -53.0% |
| 2016 | $-72.92M | - |